HSBC Holdings’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14M | Buy |
185,967
+159,026
| +590% | +$12.6M | 0.01% | 839 |
|
|
2025
Q4 | $2.14M | Sell |
26,941
-18,515
| -41% | -$1.39M | ﹤0.01% | 1539 |
|
|
2025
Q3 | $2.95M | Sell |
45,456
-62,838
| -58% | -$3.07M | ﹤0.01% | 1370 |
|
|
2025
Q2 | $4.29M | Buy |
108,294
+33,461
| +45% | +$1.1M | ﹤0.01% | 1214 |
|
|
2025
Q1 | $2.22M | Sell |
74,833
-8,222
| -10% | -$269K | ﹤0.01% | 1405 |
|
|
2024
Q4 | $2.93M | Buy |
+83,055
| New | +$3.1M | ﹤0.01% | 1318 |
|
|
2024
Q3 | – | Sell |
-5,326
| Closed | -$252K | – | 3064 |
|
|
2024
Q2 | $252K | Buy |
+5,326
| New | +$218K | ﹤0.01% | 2410 |
|
|
2023
Q2 | – | Sell |
-6,623
| Closed | -$234K | – | 2649 |
|
|
2023
Q1 | $234K | Buy |
+6,623
| New | +$249K | ﹤0.01% | 2328 |
|
|
2022
Q3 | – | Sell |
-47,206
| Closed | -$1.78M | – | 3089 |
|
|
2022
Q2 | $1.78M | Buy |
47,206
+40,609
| +616% | +$1.53M | ﹤0.01% | 1640 |
|
|
2022
Q1 | $242K | Buy |
+6,597
| New | +$216K | ﹤0.01% | 2896 |
|
|
2021
Q3 | – | Sell |
-9,435
| Closed | -$376K | – | 3072 |
|
|
2021
Q2 | $376K | Sell |
9,435
-4,980
| -35% | -$195K | ﹤0.01% | 2377 |
|
|
2021
Q1 | $648K | Sell |
14,415
-2,919
| -17% | -$163K | ﹤0.01% | 1830 |
|
|
2020
Q4 | $976K | Sell |
17,334
-25,841
| -60% | -$1.29M | ﹤0.01% | 1726 |
|
|
2020
Q3 | $2.06M | Buy |
43,175
+30,731
| +247% | +$1.71M | ﹤0.01% | 1264 |
|
|
2020
Q2 | $734K | Buy |
12,444
+1,130
| +10% | +$62.9K | ﹤0.01% | 1607 |
|
|
2020
Q1 | $536K | Sell |
11,314
-38,120
| -77% | -$2.12M | ﹤0.01% | 1746 |
|
|
2019
Q4 | $3.02M | Buy |
49,434
+25,707
| +108% | +$1.53M | 0.01% | 1328 |
|
|
2019
Q3 | $1.42M | Buy |
23,727
+12,147
| +105% | +$792K | ﹤0.01% | 1774 |
|
|
2019
Q2 | $745K | Buy |
11,580
+3,269
| +39% | +$231K | ﹤0.01% | 1899 |
|
|
2019
Q1 | $675K | Buy |
+8,311
| New | +$536K | ﹤0.01% | 1990 |
|
|
2016
Q3 | – | Sell |
-16,599
| Closed | -$387K | – | 2081 |
|
|
2016
Q2 | $387K | Sell |
16,599
-1,247
| -7% | -$40.2K | ﹤0.01% | 1663 |
|
|
2016
Q1 | $723K | Sell |
17,846
-2,079
| -10% | -$84.4K | ﹤0.01% | 1427 |
|
|
2015
Q4 | $1.23M | Sell |
19,925
-10,830
| -35% | -$584K | ﹤0.01% | 1403 |
|
|
2015
Q3 | $1.24M | Sell |
30,755
-8,643
| -22% | -$447K | ﹤0.01% | 1176 |
|
|
2015
Q2 | $2.27M | Buy |
39,398
+3,044
| +8% | +$194K | ﹤0.01% | 1049 |
|
|
2015
Q1 | $2.31M | Buy |
36,354
+29,937
| +467% | +$2.03M | ﹤0.01% | 1138 |
|
|
2014
Q4 | $396K | Buy |
+6,417
| New | +$317K | ﹤0.01% | 1533 |
|
|
2014
Q3 | – | Sell |
-12,108
| Closed | -$417K | – | 1767 |
|
|
2014
Q2 | $417K | Buy |
+12,108
| New | +$381K | ﹤0.01% | 1515 |
|
Other funds holding IONS
VPM
VCM
HSBC Holdings's IONS Position: Q1 2026 in Review
HSBC Holdings increased its Ionis Pharmaceuticals (IONS) stake by 590% in Q1 2026, buying an estimated $12.6M and bringing the position to 185,967 shares worth $14M. The position accounts for 0.01% of the portfolio, ranked #839.
HSBC Holdings first reported a position in IONS in Q2 2014 and has held it in 28 quarters since. 494 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- HSBC Holdings held 185,967 shares of Ionis Pharmaceuticals worth $14M as of Q1 2026.
- HSBC Holdings bought 159,026 Ionis Pharmaceuticals shares in Q1 2026, an estimated $12.6M.
- Ionis Pharmaceuticals made up 0.01% of HSBC Holdings's portfolio in Q1 2026, its #839 holding.
- HSBC Holdings first reported a position in Ionis Pharmaceuticals in Q2 2014 and has held it in 28 quarters since.
- 494 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.